Gardener’s Grove 2018
With the support of the Canadian Institutes of Health Research and its Strategy for Patient-Oriented Research, the innovative Clinical Trials Initiative brought together Canadian and international kidney researchers, patients, health care providers, and health administrators to participate in the Gardener’s Grove 2018.
The conference, held in Toronto, Canada on June 2nd and 3rd, 2018, served to increase knowledge and awareness about the conduct of innovative, pragmatic, cluster-randomized registry trials embedded into routine hemodialysis care and provided an opportunity to discuss and build support for new trial ideas.
The workshop content included structured presentations, facilitated group discussions, and expert panel feedback.
The Gardener’s Grove 2018 presentations included:
The Case for Intradialytic Exercise Programming
Testing a New Locking Solution for Better Hemodialysis Catheter Care
Beta Blocker Optimization in Hemodialysis
Bringing Diabetes Case Management into the Hemodialysis Unit
Frequency of Bloodwork for Patients on Hemodialysis
Ethical Issues in Pragmatic Trials in Hemodialysis Units in Ontario
The workshop brought together 111 individuals from diverse backgrounds from all over the world.
Participants included representatives from several organizations: the CIHR, the Canadian Nephrology Trials Network, the Canadian Society of Nephrology, the Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease (Can-SOLVE CKD) Network, the Ontario ICES KDT provincial program, Kidney Foundation of Canada, the Ontario Renal Network (ORN), and the Ontario SPOR SUPPORT Unit.
Partnerships and promising trial ideas borne out of the workshop will continue to be developed to support the implementation of future large-scale trials.
The Trial proceedings were published in The Canadian Journal of Kidney Health and Disease on December 26, 2019, titled “Cultivating Innovative Pragmatic Cluster-Randomized Registry Trials Embedded in Hemodialysis Care: Workshop Proceedings From 2018.”